Arcus Biosciences - Funding, Financials, Valuation, Investors - Cointime

Bitcoin $82,110.70 -2.59%
Ethereum $1,906.04 -1.65%
BNB $630.89 +0.81%
Optimism $0.85 -5.96%
Arbitrum $0.36 -3.41%
Solana $124.08 -4.28%
Polygon $0.21 -4.18%
Cosmos $4.64 +0.16%
Avalanche $18.68 -1.24%

Bitcoin $82,110.70 -2.59%
Ethereum $1,906.04 -1.65%
BNB $630.89 +0.81%
Optimism $0.85 -5.96%
Arbitrum $0.36 -3.41%
Solana $124.08 -4.28%
Polygon $0.21 -4.18%
Cosmos $4.64 +0.16%
Avalanche $18.68 -1.24%

Arcus Biosciences

company

Investors

Number of Lead Investors

Number of Investors

3

18

Arcus Biosciences is funded by 18 investors. Gilead Sciences and GV are the most recent investors.

Investor Name	Lead Investor	Funding Round
Gilead Sciences	Yes	Post-IPO Equity
GV	Yes	Series C
Aisling Capital	-	Series C
Biotechnology Value Fund	-	Series C
Celgene	-	Series C
Decheng Capital	-	Series C
Droia Ventures	-	Series C
EcoR1 Capital	-	Series C
Foresite Capital	-	Series C
Hillhouse Capital Group	-	Series C
Invus	-	Series C
Leerink Partners	-	Series C
Taiho Ventures	-	Series C
The Column Group	-	Series C
Wellington Management	-	Series C
Novartis	-	Series B
RTA Capital	-	Series B
Stanford University	-	Series B